MSR149 Modeling Price Premiums of Oncology Drugs in Germany: A Cross-Validated Analysis Using XGBoost
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.3433
https://www.valueinhealthjournal.com/article/S1098-3015(25)06058-9/fulltext
Title :
MSR149 Modeling Price Premiums of Oncology Drugs in Germany: A Cross-Validated Analysis Using XGBoost
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)06058-9&doi=10.1016/j.jval.2025.09.3433
First page :
Section Title :
Open access? :
No
Section Order :
11913